About Us

MicroTransponder Inc. is a medical device development company with a strong neuroscience research focus. An experienced team of scientists and engineers is developing a wireless neurostimulation technology platform to treat various forms of neurological disease. The lead indication is chronic pain, but other products in the development pipeline will treat tinnitus, motor and speech deficit after TBI and anxiety. MicroTransponder has a substantial neurostimulation focused R&D program which includes an initiative to use the SAINT™ to assist the delivery of chemotherapy treatments for glioblastoma and other cancer therapeutics. MicroTransponder has raised more than $17M in private investment and grants, including 8 NIH grants.